Wired

Trump’s FDA Cuts Are Putting Drug Development at Risk

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.

Kartavya NewsKartavya News
Mar 4, 2025 - 19:30
 0
Trump’s FDA Cuts Are Putting Drug Development at Risk
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.
Read More

Tags:

Previous Article

Honor’s New AI Agent Can Read and Understand Your Screen

Next Article

Elon Musk’s $1 Spending Limit Is Paralyzing Federal Agencies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Kartavya News
Kartavya News

Related Posts

Temu and Shein Raised Prices, Removed Products as Trump’s China Tariffs Went Into Effect

Temu and Shein Raised Prices, Removed Products as Trump...

Kartavya News Feb 8, 2025  0

I Took Grindr’s AI Wingman for a Spin. Here’s a Glimpse of Your Dating Future

I Took Grindr’s AI Wingman for a Spin. Here’s a Glimpse...

Kartavya News Feb 11, 2025  0

Trump Still Considering Tariffs on Taiwanese Chips, Despite $100 Billion TSMC Deal

Trump Still Considering Tariffs on Taiwanese Chips, Des...

Kartavya News Mar 5, 2025  0